Acurx Pharmaceuticals, Inc. (ACXP)
3.68
-0.21
(-5.40%)
USD |
NASDAQ |
Apr 02, 16:00
3.69
+0.01
(+0.27%)
After-Hours: 20:00
Acurx Pharmaceuticals EPS Diluted (Quarterly) : -0.6722 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apyx Medical Corp. | -0.0308 |
| Adial Pharmaceuticals, Inc. | -1.797 |
| Quince Therapeutics, Inc. | -0.2492 |
| Lantern Pharma, Inc. | -0.362 |
| Sensei Biotherapeutics, Inc. | -3.915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.578M |
| Total Expenses (Quarterly) | 1.578M |
| Enterprise Value | 1.816M |
| Earnings Yield | -111.5% |
| Normalized Earnings Yield | -111.50 |